No consensus exists at present regarding the use of imaging for the evaluation of prostate cancer.
Ultrasonography is mainly used for biopsy guidance and magnetic resonance imaging is the mainstay in evaluating the extent of local tumor. Computed tomography and radionuclide bone scanning are mainly reserved for assessment of advanced disease. Positron emission tomography is gaining acceptance in the evaluation of treatment response and recurrence. The combination of anatomic, functional, and metabolic imaging modalities has promise to improve treatment. This article reviews current imaging techniques and touches on the evolving technologies being used for detection and follow-up of prostate cancer.
Written by:
Talab SS, Preston MA, Elmi A, Tabatabaei S. Are you the author?
Department of Urology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, GRB-1102, Boston, MA 02114, USA.
Reference: Radiol Clin North Am. 2012 Nov;50(6):1015-41.
doi: 10.1016/j.rcl.2012.08.004
PubMed Abstract
PMID: 23122036
UroToday.com Prostate Cancer Section
